X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33344) 33344
Book Review (4805) 4805
Publication (3988) 3988
Newsletter (248) 248
Book Chapter (204) 204
Conference Proceeding (158) 158
Dissertation (35) 35
Book / eBook (27) 27
Magazine Article (11) 11
Data Set (6) 6
Reference (4) 4
Paper (3) 3
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (30047) 30047
animals (22041) 22041
hypertrophy (17438) 17438
male (14990) 14990
humans (13475) 13475
rats (11400) 11400
mice (7376) 7376
female (7269) 7269
cardiac & cardiovascular systems (6603) 6603
heart (4921) 4921
myocardium - metabolism (4901) 4901
cardiac-hypertrophy (4776) 4776
physiology (4567) 4567
cell biology (4476) 4476
expression (4325) 4325
peripheral vascular disease (4032) 4032
hypertension (4027) 4027
rats, sprague-dawley (3736) 3736
heart failure (3677) 3677
heart-failure (3671) 3671
cells, cultured (3591) 3591
middle aged (3468) 3468
disease models, animal (3360) 3360
biochemistry & molecular biology (3332) 3332
gene expression (3306) 3306
left-ventricular hypertrophy (3207) 3207
signal transduction (3172) 3172
gene-expression (3105) 3105
adult (3077) 3077
myocardium - pathology (3071) 3071
rodents (2955) 2955
physiological aspects (2862) 2862
endocrinology & metabolism (2796) 2796
proteins (2761) 2761
myocytes, cardiac - metabolism (2730) 2730
pharmacology & pharmacy (2656) 2656
research (2655) 2655
rats, wistar (2617) 2617
oxidative stress (2520) 2520
cardiac hypertrophy (2502) 2502
aged (2449) 2449
fibrosis (2438) 2438
abridged index medicus (2437) 2437
mice, inbred c57bl (2370) 2370
apoptosis (2340) 2340
phosphorylation (2306) 2306
article (2270) 2270
analysis (2268) 2268
time factors (2260) 2260
activation (2224) 2224
cardiomegaly - metabolism (2135) 2135
metabolism (2026) 2026
blood pressure (2023) 2023
echocardiography (2002) 2002
risk factors (1961) 1961
rna, messenger - metabolism (1905) 1905
cells (1904) 1904
mice, knockout (1828) 1828
cardiomyopathy (1810) 1810
medicine, research & experimental (1793) 1793
growth (1743) 1743
disease (1706) 1706
urology & nephrology (1694) 1694
cardiomyocytes (1671) 1671
heart diseases (1650) 1650
health aspects (1614) 1614
gene expression regulation (1602) 1602
myocytes, cardiac - pathology (1600) 1600
blood-pressure (1564) 1564
multidisciplinary sciences (1563) 1563
cardiology (1555) 1555
inflammation (1546) 1546
myocardial-infarction (1543) 1543
mice, transgenic (1529) 1529
medicine (1504) 1504
research article (1476) 1476
cardiomegaly - pathology (1473) 1473
hypertension - physiopathology (1461) 1461
angiotensin-ii (1456) 1456
myocytes, cardiac - drug effects (1435) 1435
calcium - metabolism (1426) 1426
hypertrophy, left ventricular - physiopathology (1416) 1416
in-vivo (1406) 1406
inhibition (1389) 1389
skeletal-muscle (1389) 1389
exercise (1364) 1364
hematology (1352) 1352
diabetes (1313) 1313
pressure-overload (1313) 1313
blood pressure - drug effects (1305) 1305
immunohistochemistry (1285) 1285
cardiovascular (1273) 1273
cardiovascular system (1268) 1268
organ size (1264) 1264
cardiovascular disease (1248) 1248
heart enlargement (1232) 1232
heart failure - metabolism (1230) 1230
rat (1225) 1225
kinases (1219) 1219
cardiomegaly - physiopathology (1201) 1201
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (33088) 33088
Russian (151) 151
French (112) 112
Chinese (101) 101
German (98) 98
Japanese (61) 61
Spanish (61) 61
Italian (43) 43
Polish (41) 41
Portuguese (22) 22
Hungarian (9) 9
Czech (5) 5
Turkish (5) 5
Ukrainian (5) 5
Swedish (4) 4
Danish (3) 3
Korean (3) 3
Dutch (2) 2
Norwegian (2) 2
Finnish (1) 1
Persian (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 2010, Volume 299, Issue 5, pp. E695 - E705
Deldicque L, Cani PD, Philp A, Raymackers JM, Meakin PJ, Ashford ML, Delzenne NM, Francaux M, Baar K. The unfolded protein response is activated in skeletal... 
Ribosomal protein S6 kinase | X box binding protein-1 | Binding protein | Protein synthesis | Endoplasmic reticulum stress | KINASE PATHWAY | PHYSIOLOGY | ER-STRESS | ALZHEIMERS-DISEASE | protein synthesis | ENDOPLASMIC-RETICULUM STRESS | endoplasmic reticulum stress | binding protein | DIABETES-MELLITUS | INDUCED HYPERTROPHY | MESSENGER-RNA | ribosomal protein S6 kinase | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | GLUCOSE-TOLERANCE | Dietary Fats - metabolism | Transcription Factor CHOP - genetics | Endoribonucleases - genetics | eIF-2 Kinase - metabolism | Endoplasmic Reticulum - metabolism | Muscle, Skeletal - metabolism | Muscle Fibers, Skeletal - metabolism | X-Box Binding Protein 1 | Muscle Proteins - biosynthesis | RNA - genetics | DNA-Binding Proteins - metabolism | Dietary Fats - administration & dosage | Serine Endopeptidases - genetics | Female | Protein-Serine-Threonine Kinases - metabolism | eIF-2 Kinase - genetics | Cell Line | Endoribonucleases - metabolism | Down-Regulation | Mice, Inbred C57BL | Oligopeptides - genetics | Protein-Serine-Threonine Kinases - genetics | Activating Transcription Factor 4 - genetics | Oligopeptides - metabolism | Random Allocation | Transcription Factors - genetics | DNA-Binding Proteins - genetics | RNA - chemistry | Reverse Transcriptase Polymerase Chain Reaction | Regulatory Factor X Transcription Factors | Transcription Factors - metabolism | Animals | Activating Transcription Factor 4 - metabolism | Mice | Serine Endopeptidases - metabolism | Transcription Factor CHOP - metabolism | Unfolded Protein Response - physiology | Protein folding | Physiological aspects | Muscles | Protein biosynthesis | Genetic aspects | Research | Ketogenic diet | Musculoskeletal system | Phosphorylation | Diet | Oils & fats | Insulin resistance | Physiology | Gene expression | Index Medicus
Journal Article
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 08/2016, Volume 311, Issue 2, pp. H347 - H363
Dramatic maturational changes in cardiac energy metabolism occur in the newborn period, with a shift from glycolysis to fatty acid oxidation. Acetylation and... 
Lysine acetylation | Lysine succinylation | Myocardial fatty acid oxidation | Newborn heart | MITOCHONDRIAL-PROTEIN-ACETYLATION | BIVENTRICULAR WORKING HEARTS | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | GLUCOSE-OXIDATION | lysine acetylation | NEONATAL RABBIT HEARTS | lysine succinylation | FATTY-ACID OXIDATION | INSULIN-RESISTANCE | CARDIAC-HYPERTROPHY | PERIPHERAL VASCULAR DISEASE | OVERLOAD HYPERTROPHY | myocardial fatty acid oxidation | CONTRACTILE FUNCTION | newborn heart | Phosphoglycerate Mutase - metabolism | Immunoprecipitation | Mitochondria, Heart - metabolism | 3-Hydroxyacyl CoA Dehydrogenases - metabolism | Immunoblotting | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Mitochondrial Proteins - metabolism | Adenosine Triphosphate - metabolism | Myocardium - metabolism | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha - metabolism | Lysine - metabolism | Acetylation | Fatty Acids - metabolism | Fetal Heart - metabolism | Animals, Newborn | Cell Line | Rabbits | Oxidation-Reduction | Acyl-CoA Dehydrogenase, Long-Chain - metabolism | Rats | Nerve Tissue Proteins - genetics | Nerve Tissue Proteins - metabolism | Animals | Energy Metabolism | Succinic Acid - metabolism | Glycolysis | Protein Processing, Post-Translational | Hexokinase - metabolism | In Vitro Techniques | Heart | Infants (Newborn) | Physiological aspects | Energy metabolism | Bioenergetics | Phosphorylation | RNA-protein interactions | Metabolism | Kinases | Fatty acids | Adenosine triphosphatase | Index Medicus
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 06/2009, Volume 296, Issue 6, pp. 1258 - 1270
Myostatin is a negative regulator of skeletal muscle size, previously shown to inhibit muscle cell differentiation. Myostatin requires both Smad2 and Smad3... 
MAFbx | Mammalian target of rapamycin complex signaling | MuRF1 | S6 kinase | Smad signaling | Human skeletal muscle cells | Transducer of regulated Ca | responsive element-binding protein activity | MuRF-1 | Atrogin | Transforming growth factor-β-like molecules | IGF-I | PHYSIOLOGY | ATROPHY | RAPID DISUSE | human skeletal muscle cells | transforming growth factor-beta-like molecules | SKELETAL-MUSCLE HYPERTROPHY | FOXO TRANSCRIPTION FACTORS | UBIQUITIN LIGASES | transducer of regulated Ca2+-responsive element-binding protein activity | CELL BIOLOGY | atrogin | PATHWAY | GROWTH | GENE-EXPRESSION | mammalian target of rapamycin complex signaling | CONDITIONAL ACTIVATION | Activin Receptors, Type I - antagonists & inhibitors | Protein Kinases - metabolism | Phosphorylation | Protein Kinases - genetics | Humans | Smad3 Protein - metabolism | Muscle Fibers, Skeletal - drug effects | Tripartite Motif Proteins | Smad3 Protein - genetics | Transfection | RNA Interference | Myoblasts, Skeletal - pathology | Smad2 Protein - genetics | Muscle Proteins - metabolism | Dioxoles - pharmacology | Regulatory-Associated Protein of mTOR | Benzamides - pharmacology | Myostatin - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Rapamycin-Insensitive Companion of mTOR Protein | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Signal Transduction | Cell Size - drug effects | Cells, Cultured | Smad2 Protein - metabolism | Ubiquitin-Protein Ligases - metabolism | Organ Size | Activin Receptors, Type I - metabolism | Myoblasts, Skeletal - enzymology | SKP Cullin F-Box Protein Ligases - metabolism | Mice, SCID | Myostatin - antagonists & inhibitors | Adaptor Proteins, Signal Transducing | Animals | Carrier Proteins - metabolism | Proteins - metabolism | Cell Differentiation - drug effects | Follistatin - pharmacology | Muscle Fibers, Skeletal - pathology | Creatine Kinase - metabolism | Mice | Protein Kinase Inhibitors - pharmacology | TOR Serine-Threonine Kinases | Myoblasts, Skeletal - drug effects | Insulin-Like Growth Factor I - metabolism | Muscle Fibers, Skeletal - enzymology | RNA, Small Interfering - metabolism | Abdominal surgery | Musculoskeletal system | Signal transduction | Cell growth | Kinases | Gene expression | Cells | Index Medicus
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 10/2017, Volume 32, Issue 10, pp. 2049 - 2061
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 12/2009, Volume 297, Issue 6, pp. 2096 - 2108
Diabetic cardiomyopathy is an important contributor to diastolic and systolic heart failure. We examined the nature and mechanism of the cardiomyopathy in... 
Sarco(endo)plasmic reticulum calcium-ATPase 2a | Insulin | Fibrosis | Hypertrophy | OVERLOAD | PROTEIN-KINASE-C | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | insulin | MECHANISM | hypertrophy | HEART-FAILURE | CHRONIC ACTIVATION | sarco(endo)plasmic reticulum calcium-ATPase 2a | INSULIN-RESISTANCE | EJECTION FRACTION | PERIPHERAL VASCULAR DISEASE | fibrosis | MICE | EXPRESSION | Cardiomyopathies - diagnostic imaging | Mitochondria, Heart - metabolism | Age Factors | Diastole | Natriuretic Peptide, Brain - metabolism | Diabetes Mellitus, Type 1 - metabolism | Myocardial Contraction - drug effects | Male | Diabetes Mellitus, Type 1 - diagnostic imaging | Diabetes Mellitus, Type 1 - complications | Systole | Insulin - blood | Echocardiography, Doppler, Pulsed | Myosin Heavy Chains - metabolism | Cardiomyopathies - genetics | Cardiomyopathies - physiopathology | Diglycerides - metabolism | Ventricular Dysfunction, Left - genetics | Mice, Mutant Strains | Myocardium - metabolism | Lipid Metabolism - genetics | Insulin - genetics | Fatty Acids - metabolism | Protein-Serine-Threonine Kinases - metabolism | Disease Models, Animal | Cardiomyopathies - drug therapy | Insulin - pharmacology | Sarcoplasmic Reticulum Calcium-Transporting ATPases - metabolism | Ceramides - metabolism | Acyl-CoA Dehydrogenase, Long-Chain - metabolism | Diabetes Mellitus, Type 1 - physiopathology | Mice, Inbred C57BL | Diabetes Mellitus, Type 1 - genetics | Disease Progression | Ventricular Dysfunction, Left - diagnostic imaging | Ventricular Dysfunction, Left - physiopathology | Diabetes Mellitus, Type 1 - drug therapy | Hypoglycemic Agents - pharmacology | Triglycerides - metabolism | Stroke Volume | Ventricular Dysfunction, Left - metabolism | Animals | Ventricular Dysfunction, Left - drug therapy | Cardiomyopathies - metabolism | Lipid Metabolism - drug effects | Mice | Ventricular Pressure | Blood Glucose - metabolism | Heart failure | Complications and side effects | Prognosis | Cardiomyopathy | Type 1 diabetes | Heart diseases | Risk factors | Heart | Rodents | Oxidation | Glucose | Diabetes | Kinases | Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 06/2012, Volume 125, Issue 23, pp. 2844 - 2853
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 06/2009, Volume 296, Issue 6, pp. 1248 - 1257
Loss of muscle mass occurs in a variety of diseases, including cancer, chronic heart failure, aquired immunodeficiency syndrome, diabetes, and renal failure,... 
Myostatin | Muscle atrophy | Akt | Hypertrophy | MYOBLAST DIFFERENTIATION | PHYSIOLOGY | hypertrophy | MYOSTATIN GENE | UBIQUITIN LIGASES | myostatin | CELL BIOLOGY | SKELETAL-MUSCLE | IN-VIVO | GROWTH | ATROPHY INVOLVE | MICE | muscle atrophy | EXPRESSION | Phosphorylation | Receptors, Transforming Growth Factor beta - genetics | Age Factors | Muscle Denervation | Male | Muscle, Skeletal - innervation | Muscle, Skeletal - metabolism | Smad3 Protein - metabolism | Proto-Oncogene Proteins c-akt - genetics | Tripartite Motif Proteins | Muscle Development | Muscular Atrophy - physiopathology | Transfection | RNA Interference | Muscle Proteins - metabolism | Cell Differentiation | Muscular Atrophy - prevention & control | Myostatin - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Protein-Serine-Threonine Kinases - metabolism | Disease Models, Animal | Muscular Atrophy - metabolism | Signal Transduction | Muscular Atrophy - pathology | Cells, Cultured | Protein-Serine-Threonine Kinases - genetics | Smad2 Protein - metabolism | Ubiquitin-Protein Ligases - metabolism | Mice, Transgenic | Phosphotransferases (Alcohol Group Acceptor) - metabolism | Animals | Carrier Proteins - metabolism | Receptors, Transforming Growth Factor beta - metabolism | Sciatic Nerve - surgery | Muscle, Skeletal - physiopathology | Mice | TOR Serine-Threonine Kinases | Muscle, Skeletal - pathology | Mutation | Transforming Growth Factor beta - metabolism | RNA, Small Interfering - metabolism | Proteins | Signal transduction | Musculoskeletal system | Adults | Cells | Index Medicus
Journal Article
Antioxidants and Redox Signaling, ISSN 1523-0864, 10/2010, Volume 13, Issue 7, pp. 1011 - 1022
Journal Article
Diabetes, ISSN 0012-1797, 09/2015, Volume 64, Issue 9, pp. 3121 - 3134
Inflammation and lipid accumulation are hallmarks of muscular pathologies resulting from metabolic diseases such as obesity and type 2 diabetes. During... 
SKELETAL-MUSCLE | HYPERTROPHY | VISCERAL FAT | ENDOTHELIAL-CELLS | ENDOCRINOLOGY & METABOLISM | BODY-FAT DISTRIBUTION | DIFFERENTIATION | ASSOCIATION | EXPRESSION | ADIPOSE-TISSUE | INFILTRATION | Tumor Necrosis Factor-alpha - metabolism | Coculture Techniques | Humans | Obesity, Morbid - immunology | Male | Intra-Abdominal Fat - cytology | Muscle Fibers, Skeletal - metabolism | Subcutaneous Fat - immunology | Insulin-Like Growth Factor Binding Protein 5 - pharmacology | Subcutaneous Fat - metabolism | Interleukin-1beta - metabolism | Insulin-Like Growth Factor II - pharmacology | Tumor Necrosis Factor-alpha - immunology | Interleukin-10 - metabolism | Adult | Female | Contractile Proteins - metabolism | Interleukin-6 - metabolism | Obesity, Morbid - metabolism | Adipocytes - immunology | Cytokines - immunology | Intra-Abdominal Fat - immunology | Atrophy - immunology | Gene Expression Regulation | Interleukin-1beta - immunology | Inflammation | Intra-Abdominal Fat - metabolism | Muscle Fibers, Skeletal - immunology | Subcutaneous Fat - cytology | Animals | Adipocytes - metabolism | Interleukin-6 - immunology | Muscle Fibers, Skeletal - pathology | Mice, Obese | Mice | Atrophy - metabolism | Interleukin-10 - immunology | Atrophy | Obesity | Complications and side effects | Fat cells | Research | Lipid metabolism | Risk factors | Proteins | Cytokines | Adipocytes | Muscular system | Metabolism | Gene expression | Index Medicus | Abridged Index Medicus
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 07/2014, Volume 34, Issue 7, pp. 1399 - 1411
OBJECTIVE—S100A12 and fibroblast growth factor 23 are biomarkers of cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD). We... 
renal insufficiency chronic | S100 proteins | glycosylation end products advanced | hypertrophy left ventricular | MORTALITY | renal insufficiency, chronic | VASCULAR CALCIFICATION | hypertrophy, left ventricular | RAGE | ARTERIAL CALCIFICATION | glycosylation end products, advanced | GROWTH-FACTOR 23 | HEMODIALYSIS-PATIENTS | NULL MICE | S100A12 | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | EXPRESSION | SOLUBLE RECEPTOR | Calgranulin B - metabolism | Diastole | Humans | Calgranulin A - genetics | Renal Insufficiency, Chronic - complications | Sclerosis | S100A12 Protein | Fibroblast Growth Factors - metabolism | Inflammation - metabolism | S100 Proteins - genetics | Hypertrophy, Left Ventricular - genetics | Calcinosis - etiology | Time Factors | Myocardium - metabolism | Renal Insufficiency, Chronic - genetics | Receptor for Advanced Glycation End Products | Disease Models, Animal | Fibroblasts - metabolism | Signal Transduction | Receptors, Immunologic - deficiency | Genotype | Mice, Transgenic | S100 Proteins - metabolism | Mice, Knockout | Ventricular Dysfunction, Left - metabolism | Phenotype | Heart Valve Diseases - metabolism | Heart Valve Diseases - genetics | Mice | Hypertrophy, Left Ventricular - physiopathology | Receptors, Immunologic - genetics | Heart Valve Diseases - pathology | Ventricular Function, Left | Calgranulin A - metabolism | Leukocyte L1 Antigen Complex - metabolism | Aortic Valve - pathology | Renal Insufficiency, Chronic - metabolism | Inflammation - complications | Ventricular Remodeling | Inflammation Mediators - metabolism | Calgranulin B - genetics | Calcinosis - metabolism | Hypertrophy, Left Ventricular - etiology | Hypertrophy, Left Ventricular - metabolism | Mice, Inbred C57BL | Cells, Cultured | Ventricular Dysfunction, Left - etiology | Heart Valve Diseases - etiology | Aortic Valve - metabolism | Ventricular Dysfunction, Left - physiopathology | Animals | Inflammation - genetics | Leukocyte L1 Antigen Complex - genetics | Receptors, Immunologic - metabolism | Index Medicus
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 2017, Volume 312, Issue 1, pp. H128 - H140
Duchenne Muscular Dystrophy (DMD) is associated with progressive cardiac pathology; however, the SIRT1/PGC1-alpha activator quercetin may cardioprotect... 
Polyphenol | Duchenne muscular dystrophy | Utrophin | RESVERATROL | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | PGC-1-ALPHA | PATHOLOGY | polyphenol | utrophin | PREVENTS | MDX MICE | SKELETAL-MUSCLE | MUSCLE MITOCHONDRIAL BIOGENESIS | CARDIAC-HYPERTROPHY | PERIPHERAL VASCULAR DISEASE | DUCHENNE MUSCULAR-DYSTROPHY | EXPRESSION | Utrophin - metabolism | Phosphorylation | Muscular Dystrophy, Animal - physiopathology | Mitochondria, Muscle - metabolism | Transforming Growth Factor beta1 - metabolism | Utrophin - genetics | Citrate (si)-Synthase - drug effects | NF-kappa B - metabolism | Motor Activity | Receptors, IgG - metabolism | Matrix Metalloproteinase 9 - metabolism | Myocardium - metabolism | Mice, Inbred mdx | Muscular Dystrophy, Animal - metabolism | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha - metabolism | Transforming Growth Factor beta1 - drug effects | Antigens, Differentiation - metabolism | Citrate (si)-Synthase - metabolism | Superoxide Dismutase - metabolism | Cytochromes c - drug effects | Disease Models, Animal | Heart - physiopathology | Sarcoglycans - metabolism | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha - drug effects | Cytochromes c - metabolism | Myocardium - pathology | Cyclooxygenase 2 - drug effects | Antioxidants - pharmacology | Electron Transport Chain Complex Proteins - drug effects | Receptors, IgG - drug effects | Food, Fortified | NF-KappaB Inhibitor alpha - drug effects | Superoxide Dismutase - drug effects | Blotting, Western | Fibronectins - metabolism | Heart - diagnostic imaging | Magnetic Resonance Imaging | Animals | Quercetin - pharmacology | Electron Transport Chain Complex Proteins - metabolism | NF-KappaB Inhibitor alpha - metabolism | Cyclooxygenase 2 - metabolism | Antigens, Differentiation - drug effects | Heart - drug effects | Mice | Mitochondria, Muscle - drug effects | Muscular Dystrophy, Duchenne | NF-kappa B - drug effects | Glycoproteins | Nuclear magnetic resonance--NMR | Rodents | Medical treatment | Index Medicus
Journal Article